Jeffrey M. Jonas

DR. JEFFREY M. JONAS, MD, is President and Chief Executive Officer of
AVAX Technology, Inc. and has extensive experience in pharmaceutical
development, including the areas of biotechnology, pharmacoeconomics,
and psychopharmacology, as well as the acquisition and development of
new cancer, antibiotic and immunological drugs. From 1994 to 1996, Dr.
Jonas was Vice President of Clinical Development and Chief Medical
Officer of Upjohn Laboratories. From 1991 to 1996, Dr. Jonas held
positions at the Upjohn Company as Vice President of Worldwide
Pharmaceutical Regulatory Affairs, Director of Psychopharmacology and
Vice President of Clinical Development. Dr. Jonas is the author of a
book on Prozac_ and over 100 scientific articles, abstracts, and book
chapters. Dr. Jonas received his MD from Harvard Medical School in 1979
and a BA in Biology and English from Amherst College in 1975.